Aerogen® and CanSinoBIO Agree on Landmark Development and Commercial Supply Partnership for World’s First Inhaled Covid-19 Vaccine Delivery

GALWAY, Ireland — Following months of collaborative development work, Aerogen® (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) have announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIO’s Recombinant Novel Coronavirus Vaccine Convidecia™ utilizing Aerogen’s proprietary vibrating mesh aerosol drug delivery technology. Read More